糖尿病性白内障患者滤蓝光人工晶体植入术临床观察

Clinical observation of blue-light-filtering intraocular lenses implantation on treating patients with diabetes cataract

目的：探讨糖尿病性白内障患者植入滤蓝光人工晶体治疗效果，为患者白内障术后提供更舒适的选择。方法收集糖尿病白内障患者100例（100只眼），随机分组，50例植入普通可折叠人工晶体、50例植入滤蓝光人工晶体，术后观察最佳矫正视力、并发症，对主观视觉质量问卷调查。结果两组术后1周、1个月最佳矫正视力差异无统计学意义（ P ＞0.05）。两组患者术后早期并发症差异无统计学意义（ P ＞0.05）。两组术后1周视功能调查表指标分数比较差异有统计学意义（ P ＜0.05）。结论血糖控制在一定水平以内，滤蓝光人工晶体可以为糖尿病白内障患者提供更好选择。

Objective To explore therapeutic efficacy of blue-light-filtering intraocular lenses implantation on treating patients with diabetes cataract , and provide a more comfortable choice after phacoemulsification （ PHACO） and intraocularlens （ IOL） implan-tation.Methods A total of 100 cases （100 eyes） of patients with diabetes cataract was collected , and was randomly divided into group I （ n =50, implanted ordinary intraocular lenses ） and group II （ n =50, implanted blue-light-filtering intraocular lenses）.Af-ter surgery, the best-corrected vision and postoperative complications were reported .The subjective visual performance was evaluated by questionnaire .Results At 1 week and 1 month after surgery , the best-corrected vision had no significant differences between two groups （ P ＆gt;0.05 ） .Early complication after surgery was not significantly different between two groups （ P ＆gt;0.05 ） .The subjective visual performance in the blue-light-filtering intraocular lenses group was significantly better than that in the ordinary intraocular lenses group （ P ＆lt;0.05 ） .Conclusions When the blood sugar is controlled in certain level , it is possible for the blue-light-filtering in-traocular lenses to provide a better choice for patients with diabetes cataract .